Style de citation APA (7e éd.)
Haque, A. A. (2026). AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST.
Style de citation Chicago (17e éd.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. Dhaka: BME DEPT. MIST, 2026.
Style de citation MLA (9e éd.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST, 2026.
Attention : ces citations peuvent ne pas être correctes à 100%.